top of page

About Us
Journal
Technology
Pipeline
Engage
Contact

Canurta Website Images.jpg

Canurta Journal

A collection of news, scientific papers and impact across industry, academia and events.

All Posts
Research
Events
Awards
News
Blog

The Science Behind Developing Plant-Based Medications

The Science Behind Developing Plant-Based Medications

The Science Behind Developing Plant-Based Medications

May 3

Canurta’s Research at the ALS/MND Symposium

Canurta’s Research at the ALS/MND Symposium

Canurta’s Research at the ALS/MND Symposium

Jan 22

Cannabinoids as Potential Therapeutics for ALS: An Overview from Preclinical and Clinical Studies

Cannabinoids as Potential Therapeutics for ALS: An Overview from Preclinical and Clinical Studies

Cannabinoids as Potential Therapeutics for ALS: An Overview from Preclinical and Clinical Studies

Dec 9, 2024

Optimization of Cannflavin Production in Germinated Hemp Seeds: Insights into Metabolomic and Antioxidant Profiles

Optimization of Cannflavin Production in Germinated Hemp Seeds: Insights into Metabolomic and Antioxidant Profiles

Optimization of Cannflavin Production in Germinated Hemp Seeds: Insights into Metabolomic and Antioxidant Profiles

Dec 2, 2024

Medical Marijuana for ALS Symptom Management: Potential Benefits and Risks in Disease Progression

Medical Marijuana for ALS Symptom Management: Potential Benefits and Risks in Disease Progression

Medical Marijuana for ALS Symptom Management: Potential Benefits and Risks in Disease Progression

Nov 25, 2024

Cannabistilbene I as a Potential Therapeutic for Cardiac Hypertrophy: Modulating Key Enzymes and Metabolic Pathways

Cannabistilbene I as a Potential Therapeutic for Cardiac Hypertrophy: Modulating Key Enzymes and Metabolic Pathways

Cannabistilbene I as a Potential Therapeutic for Cardiac Hypertrophy: Modulating Key Enzymes and Metabolic Pathways

Oct 11, 2024

3-Minute Pitch at ACT Canada Consortium: Advancing ALS Treatment with CNR-401

3-Minute Pitch at ACT Canada Consortium: Advancing ALS Treatment with CNR-401

3-Minute Pitch at ACT Canada Consortium: Advancing ALS Treatment with CNR-401

Oct 10, 2024

FDA Drug Approvals in 2023: Insights into Trends and Molecule Types

FDA Drug Approvals in 2023: Insights into Trends and Molecule Types

FDA Drug Approvals in 2023: Insights into Trends and Molecule Types

Aug 21, 2024

The Gut-Brain Axis: Exploring the Impact of Gut Microbiota-Derived Phenolic Compounds on Neurocognition

The Gut-Brain Axis: Exploring the Impact of Gut Microbiota-Derived Phenolic Compounds on Neurocognition

The Gut-Brain Axis: Exploring the Impact of Gut Microbiota-Derived Phenolic Compounds on Neurocognition

Aug 14, 2024

Cannflavin-C Counters Heart Enlargement Triggered by Angiotensin II: Impact on Enzymes and Fatty Acid Metabolism

Cannflavin-C Counters Heart Enlargement Triggered by Angiotensin II: Impact on Enzymes and Fatty Acid Metabolism

Cannflavin-C Counters Heart Enlargement Triggered by Angiotensin II: Impact on Enzymes and Fatty Acid Metabolism

Aug 7, 2024

Canurta Therapeutics Secures First US Patent for Novel Bioactive Polyphenol Extraction Process

Canurta Therapeutics Secures First US Patent for Novel Bioactive Polyphenol Extraction Process

Canurta Therapeutics Secures First US Patent for Novel Bioactive Polyphenol Extraction Process

Jul 31, 2024

Exploring Cannabis Pharmacology: Beyond THC and CBD

Exploring Cannabis Pharmacology: Beyond THC and CBD

Exploring Cannabis Pharmacology: Beyond THC and CBD

Jul 24, 2024

AI: Transforming the Future of Nutraceuticals

AI: Transforming the Future of Nutraceuticals

AI: Transforming the Future of Nutraceuticals

Jul 17, 2024

The Protective Role of Cannflavins A and B Against Cell Death in Human Skin Cells

The Protective Role of Cannflavins A and B Against Cell Death in Human Skin Cells

The Protective Role of Cannflavins A and B Against Cell Death in Human Skin Cells

Jul 8, 2024

Investigation of cannflavins from Cannabis sativa as potential anti-SARS-CoV-2 agents

Investigation of cannflavins from Cannabis sativa as potential anti-SARS-CoV-2 agents

Investigation of cannflavins from Cannabis sativa as potential anti-SARS-CoV-2 agents

Jul 1, 2024

The Antiatherogenic Potential of Flavonoids in Cardiovascular Health

The Antiatherogenic Potential of Flavonoids in Cardiovascular Health

The Antiatherogenic Potential of Flavonoids in Cardiovascular Health

Jun 24, 2024

Cannflavin A Displays Both a Hormetic and Neuroprotective Profile Against Alzheimer's Disease Progression

Jun 17, 2024

Preclinical Research with a First-in-Class ALS Therapy Formulation

Preclinical Research with a First-in-Class ALS Therapy Formulation

Preclinical Research with a First-in-Class ALS Therapy Formulation

May 24, 2024

Reflecting on the ALS Drug Development Summit in Boston

Reflecting on the ALS Drug Development Summit in Boston

Reflecting on the ALS Drug Development Summit in Boston

May 24, 2024

The Comprehensive Neurotherapeutic Potential of Cannabis sativa

The Comprehensive Neurotherapeutic Potential of Cannabis sativa

The Comprehensive Neurotherapeutic Potential of Cannabis sativa

Apr 9, 2024

Transforming Rare Polyphenols into Botanical Drugs

hello@canurta.com |

© 2024 Canurta, Inc. All rights reserved.

Stay connected & receive updates on new discoveries, product innovation and more.

Thank you for subscribing.

About Us
Journal
Technology
Pipeline
Engage
Contact

bottom of page